Terms: = Leukemia AND PLAG1, ENSG00000181690, 5324
13 results:
1. [Expression Level and Target Gene Prediction of miR-181b in Patients with Chronic Lymphocytic leukemia].
Kou Z; Liu H; Wang YC; Huang Q; Wang ZS; Gu ZNE; Lang T; Nie YL; An L; A ZL; Mu HBE; Zhang XY; Fu L; Ai HJ; Mao M; Wang XM; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):808-814. PubMed ID: 32552940
[TBL] [Abstract] [Full Text] [Related]
2. Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.
Basheer F; Giotopoulos G; Meduri E; Yun H; Mazan M; Sasca D; Gallipoli P; Marando L; Gozdecka M; Asby R; Sheppard O; Dudek M; Bullinger L; Döhner H; Dillon R; Freeman S; Ottmann O; Burnett A; Russell N; Papaemmanuil E; Hills R; Campbell P; Vassiliou GS; Huntly BJP
J Exp Med; 2019 Apr; 216(4):966-981. PubMed ID: 30890554
[TBL] [Abstract] [Full Text] [Related]
3. plag1 and USF2 Co-regulate Expression of Musashi-2 in Human Hematopoietic Stem and Progenitor Cells.
Belew MS; Bhatia S; Keyvani Chahi A; Rentas S; Draper JS; Hope KJ
Stem Cell Reports; 2018 Apr; 10(4):1384-1397. PubMed ID: 29641991
[TBL] [Abstract] [Full Text] [Related]
4. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
5. MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting plag1.
Sun YP; Lu F; Han XY; Ji M; Zhou Y; Zhang AM; Wang HC; Ma DX; Ji CY
Oncotarget; 2016 May; 7(18):25276-90. PubMed ID: 27013583
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.
Atak ZK; Gianfelici V; Hulselmans G; De Keersmaecker K; Devasia AG; Geerdens E; Mentens N; Chiaretti S; Durinck K; Uyttebroeck A; Vandenberghe P; Wlodarska I; Cloos J; Foà R; Speleman F; Cools J; Aerts S
PLoS Genet; 2013; 9(12):e1003997. PubMed ID: 24367274
[TBL] [Abstract] [Full Text] [Related]
7. Frequent plag1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation.
Antonescu CR; Zhang L; Shao SY; Mosquera JM; Weinreb I; Katabi N; Fletcher CD
Genes Chromosomes Cancer; 2013 Jul; 52(7):675-82. PubMed ID: 23630011
[TBL] [Abstract] [Full Text] [Related]
8. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene plag1 by deregulated miRNAs.
Patz M; Pallasch CP; Wendtner CM
Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
[TBL] [Abstract] [Full Text] [Related]
9. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
[TBL] [Abstract] [Full Text] [Related]
10. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene plag1 in chronic lymphocytic leukemia.
Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
[TBL] [Abstract] [Full Text] [Related]
11. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.
Stenman G
Semin Cancer Biol; 2005 Jun; 15(3):224-35. PubMed ID: 15826837
[TBL] [Abstract] [Full Text] [Related]
12. plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.
Landrette SF; Kuo YH; Hensen K; Barjesteh van Waalwijk van Doorn-Khosrovani S; Perrat PN; Van de Ven WJ; Delwel R; Castilla LH
Blood; 2005 Apr; 105(7):2900-7. PubMed ID: 15585652
[TBL] [Abstract] [Full Text] [Related]
13. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of plag1 gene expression under control of the LIFR promoter.
Voz ML; Aström AK; Kas K; Mark J; Stenman G; Van de Ven WJ
Oncogene; 1998 Mar; 16(11):1409-16. PubMed ID: 9525740
[TBL] [Abstract] [Full Text] [Related]
